Researchers developed a "Trojan horse" obesity drug using GLP-1/GIP signals to deliver metabolic enhancers directly into target cells.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
New “Trojan horse” obesity drug supercharges weight loss in early tests
GLP-1/GIP Signal-Based Delivery System Drug mechanism
Appetite Suppression & Weight Loss Target effect
Much Lower Effective Doses Required Dosage advantage
Early Mouse Studies Testing stage